Search for study summaries based on condition or drug class

• ACS 27
• AF 8
• CAD +/- PCI 34
• Diabetes 8
• Dyslipidemia 20
• FH 5
• HFmrEF 4
• HFpEF 9
• HFrEF 26
• Hypertension 8
• ID 1
• Overweight/obesity 2
• SAH 1
• VTE 1
• Valvular heart disease 2
• Ventricular arrhythmias 2

• ACE inhibitors 11
• ARBs 6
• Antiarrhythmics 3
• Antiplatelets 27
• Beta-blockers 9
• CCBs 5
• CETP inhibitors 1
• Coenzyme Q10 1
• DPP-4 inhibitors 1
• Diuretics 5
• Duration 4
• Ezetimibe 3
• Fibrates 2
• GLP1RA 2
• Heparin & other parenteral anticoagulants 2
• Hydralazine-nitrate 1
• Ivabradine 1
• Labs & tests 2
• Liraglutide 1
• Mineralocorticoid receptor antagonists (MRAs) 3
• NSAIDs 2
• Natriuretic peptides 1
• Niacin 2
• P2Y12 inhibitors 2
• PCSK9 inhibitors 7
• PPI 1
• Pharmacogenomics 1
• SGLT2 inhibitors (gliflozins) 6
• Sacubitril 2
• Semaglutide 2
• Smoking cessation 1
• Statins 8
• Testosterone 1
• Vericiguat 1
• Warfarin & DOACs 13
• icosapent ethyl / omega-3 fatty acids 1
• iron 1
• non-pharmacological 1